Compare FTFT & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTFT | MBAI |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Israel |
| Employees | 40 | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 10.6M |
| IPO Year | N/A | N/A |
| Metric | FTFT | MBAI |
|---|---|---|
| Price | $2.20 | $1.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.7K | 23.7K |
| Earning Date | 11-14-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,665,719.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.96 | $0.59 |
| 52 Week High | $19.99 | $3.13 |
| Indicator | FTFT | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 71.90 | N/A |
| Support Level | $1.96 | N/A |
| Resistance Level | $2.71 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 75.19 | 0.00 |
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.